For patients requiring long-term MS infusions like Ocrevus or Tysabri, traditional hospital-based treatment comes at a significant financial and logistical cost. Leap Health provides an alternative: cost-effective, patient-friendly infusion therapy that eliminates unnecessary expenses and administrative barriers.
Key Areas Where Leap Health Saves Employers Money
Leap Health's model addresses the biggest cost drivers in MS treatment by:
March Is National MS Education and Awareness Month
March is a time to raise awareness about MS and advocate for better, more affordable care. For employers, this means recognizing the significant financial and workforce burden that MS places on their organizations and taking action to reduce these costs without sacrificing care quality.
Leap Health is committed to making MS treatment more accessible, cost-effective, and patient-friendly. By eliminating inflated infusion costs and reducing workplace disruptions, Leap helps employers provide better care while saving millions annually.